KADIAN 20 mg (Morphine Sulfate Extended-Release 20 mg)
Pill with imprint KADIAN 20 mg is Yellow, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 20 mg. It is supplied by Actavis.
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for KADIAN 20 mg
Morphine Sulfate Extended-Release
- Imprint:
- KADIAN 20 mg
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Actavis
- National Drug Code (NDC):
- 00228-3502
More about morphine
- Morphine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 312 Reviews
- Drug class: narcotic analgesics
Consumer resources
- Morphine
- Morphine Immediate-Release Tablets and Capsules
- Morphine Extended-Release Capsules
- Morphine Long-Acting Tablets
- Morphine Injection
- ... +6 more
Other brands: MS Contin, Roxanol, Kadian, MorphaBond ER, ... +8 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
